TFA Therapeutics RAJAF
OTC RAJAF
$9.18 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

TFA Therapeutics (RAJAF) Income from Discontinued Operations (2022 - 2023)

Updated

TFA Therapeutics (RAJAF) recorded Income from Discontinued Operations of $1.12 million in Q4 2023, compared with -$40,155 a year earlier.

Analysis

TFA Therapeutics (RAJAF) Income from Discontinued Operations (2022 - 2023) Analysis & Trends

For FY2023, TFA Therapeutics reported Income from Discontinued Operations of $865,085.

  • Across earlier years, Income from Discontinued Operations came in at -$304,982 in FY2022 and -$371,626 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Procter & Gamble 336.76 Bn 292.75 Bn 10.28 Bn -
2 Colgate Palmolive 67.18 Bn 62.24 Bn 3.30 Bn -
3 Estee Lauder Companies 33.32 Bn 21.40 Bn 2.74 Bn -
4 Kenvue 33.09 Bn 28.70 Bn 2.30 Bn -
5 Kimberly Clark 31.38 Bn 28.71 Bn 1.60 Bn -60.00 Mn
6 Church & Dwight 22.37 Bn 20.90 Bn 693.90 Mn -
7 Clorox 9.72 Bn 8.16 Bn 804.00 Mn -
8 e.l.f. Beauty 6.17 Bn 5.15 Bn 398.84 Mn -
9 Reynolds Consumer Products 4.71 Bn 4.37 Bn 245.00 Mn -
10 TFA Therapeutics 1.02 Bn 1.02 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 1.12 Mn
Dec 31, 2022 -40,155.00
API Access

TFA Therapeutics Income from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=RAJAF&period=max&api_key=YOUR_API_KEY